SCHEMBL14902855

SCHEMBL14902855

Cc1ccc(C(N)=NOCc2ccccc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 8/20 0.62
MAPT P10636 4/20 0.59
ALDH1A1 P00352 2/20 0.59
KDM4E B2RXH2 1/20 0.59
TDP1 Q9NUW8 3/20 0.57
USP2 O75604 1/20 0.52
CYP2D6 P10635 1/20 0.51
HIF1A Q16665 1/20 0.51
NPC1 O15118 6/20 0.51
RAB9A P51151 6/20 0.51
SMN1; SMN2 Q16637 6/20 0.51
PKM P14618 2/20 0.50
THRB P10828 1/20 0.46
LMNA P02545 1/20 0.45
MAPK1 P28482 1/20 0.44
SCN2A Q99250 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23715924 0.94 L3MBTL1 (0.55) L3MBTL1MAPTALDH1A1KDM4ETDP1
SCHEMBL8363638 0.84 SMN1; SMN2 (0.50) L3MBTL1MAPTALDH1A1KDM4ETDP1
SCHEMBL10054644 0.84 SMN1; SMN2 (0.50) L3MBTL1MAPTALDH1A1KDM4ETDP1
Hydrochloric Acid SCHEMBL6648935 0.83 MAOB (0.50) L3MBTL1MAPTALDH1A1KDM4ETDP1
Hydrochloric Acid SCHEMBL6786483 0.83 MAOB (0.50) L3MBTL1MAPTALDH1A1KDM4ETDP1
SCHEMBL23486912 0.81 L3MBTL1 (0.67) L3MBTL1MAPTALDH1A1KDM4ETDP1
SCHEMBL13606730 0.77 L3MBTL1 (0.43) L3MBTL1MAPTALDH1A1KDM4ETDP1
SCHEMBL6562382 0.77 PPARG (0.47) L3MBTL1MAPTALDH1A1KDM4ETDP1
SCHEMBL6562384 0.77 PPARG (0.47) L3MBTL1MAPTALDH1A1KDM4ETDP1
SCHEMBL14257301 0.75 NPC1 (0.50) L3MBTL1MAPTALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013062024-A1 PLANT DISEASE CONTROL AGENT CONTAINING ARYLAMIDINE DERIVATIVE OR SALT THEREOF 石原産業株式会社 (JP) 2013-05-02 WO disclosed